HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 53 filers reported holding HOMOLOGY MEDICINES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $150,000 | -23.5% | 49,206 | -8.8% | 0.00% | – |
| Q4 2021 | $196,000 | -54.3% | 53,936 | -0.9% | 0.00% | -100.0% |
| Q3 2021 | $429,000 | +1.9% | 54,452 | -5.9% | 0.00% | 0.0% |
| Q2 2021 | $421,000 | -12.8% | 57,850 | +12.7% | 0.00% | 0.0% |
| Q1 2021 | $483,000 | -16.7% | 51,348 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $580,000 | +5.6% | 51,348 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $549,000 | -29.4% | 51,348 | +0.2% | 0.00% | 0.0% |
| Q2 2020 | $778,000 | +33.7% | 51,247 | +36.9% | 0.00% | 0.0% |
| Q1 2020 | $582,000 | -27.2% | 37,446 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $800,000 | +14.4% | 38,634 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $699,000 | -4.6% | 38,634 | +3.2% | 0.00% | 0.0% |
| Q2 2019 | $733,000 | +0.5% | 37,433 | +42.3% | 0.00% | 0.0% |
| Q1 2019 | $729,000 | +21.3% | 26,302 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $601,000 | +64.7% | 26,887 | +68.2% | 0.00% | 0.0% |
| Q3 2018 | $365,000 | +12.0% | 15,987 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $326,000 | – | 15,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 5,535,919 | $86,028,000 | 26.64% |
| VV Manager LLC | 770,845 | $11,979,000 | 13.54% |
| RTW INVESTMENTS, LP | 4,399,250 | $68,364,000 | 2.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,037,305 | $62,740,000 | 1.99% |
| COWEN AND COMPANY, LLC | 476,488 | $7,405,000 | 1.70% |
| Vivo Capital, LLC | 1,008,562 | $15,673,000 | 1.42% |
| Ghost Tree Capital, LLC | 200,000 | $3,108,000 | 0.82% |
| Bellevue Group AG | 1,612,122 | $25,052,000 | 0.49% |
| Cormorant Asset Management, LP | 600,000 | $9,324,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $50,043,000 | 0.37% |